Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, has announced the appointment of Arjan Roozen as chief technology officer (CTO). 

Pharmacy2U, the UK’s largest NHS online pharmacy, has secured a further £40 million investment to support the rapid growth of its online 

TrakCel, the industry-leading software developer for cell and gene therapy supply chain tracking and orchestration, announces today it will be the organization responsible for tracking and documentation of cell and gene therapy products for the Northern Alliance Advanced Therapies Treatment Centre. 

Finnish digital health company Kaiku Health Oy, which provides intelligent patient monitoring software for healthcare providers across Europe, has closed a €4.4 million funding round. The investment was led by Debiopharm Innovation Fund SA and Tesi with participation from Prodeko Ventures Oy and existing investors Reaktor Ventures Oy, Metsola Ventures Oy, and Athensmed Oy.

LetsGetChecked, the medical health testing platform that allows customers to access regulated laboratory testing and self-test from the comfort of home.

Glyconics has signed an exclusive licensing deal with Ghent University in Belgium for its proprietary method for the measurement of Diabetes 

Archangels and Scottish Investment Bank have invested £2 million in Bio-Images Drug Delivery Limited (BDD). 

Hats off to HBAN who funded an angel deal just 48 hours after the pitch.

How did this investment which is possibly the speediest investment ever (let me know if you know of a quicker one) happen?  HBAN explained that it was partly because with previous investors, including HBAN angels, already in the deal, all the due diligence was in place.

Tikehau Capital, the pan-European alternative asset management and investment company, and SPRIM Ventures, a world-class global medical and scientific consultancy firm, has announced the initial closing of their first venture capital fund, TKS1, which will focus on early stage investments in med-tech and life science companies. 

NVM has led a £5 million growth capital minority investment into Manchester-based Currentbody, an online retailer for home-use beauty devices. Having achieved exceptional sales growth in the last year, the investment will help support its next phase of expansion, allowing the company to accelerate its strategic initiatives and support working capital requirements. 

Co-Founded by Laurence Newman and Andrew Showman, CURRENTBODY.com is the only website specialising in beauty devices for home use.

HBAN has invested €50,000 in Incereb, a neonatal monitoring sensors company, just 48 hours after hearing the Irish company’s presentation.

Doctor-on-demand app Qured has closed a joint angel and crowd raise of £1.13m through SeedLegals  and Seedrs, at a post-money valuation  of £5.16m.